Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/1787
Type: Artigo
Title: Platelet hyperaggregability in high-fat fed rats: a role for intraplatelet reactive-oxygen species production
Author: Monteiro, Priscila F.
Morganti, Rafael P.
Delbin, Maria A.
Calixto, Marina C.
Lopes-Pires, Maria E.
Marcondes, Sisi
Zanesco, Angelina
Antunes, Edson
Abstract: Adiposity greatly increases the risk of atherothrombotic events, a pathological condition where a chronic state of oxidative stress is reported to play a major role. This study aimed to investigate the involvement of (NO)-soluble guanylyl cyclase (sGC) signaling pathway in the platelet dysfunction from high fat-fed (HFF) rats. Methods: Male Wistar rats were fed for 10 weeks with standard chow (SCD) or high-fat diet (HFD). ADP (10 mu M)-and thrombin (100 mU/ml)-induced washed platelet aggregation were evaluated. Measurement of intracellular levels of ROS levels was carried out using flow cytometry. Cyclic GMP levels were evaluated using ELISA kits. Results: High-fat fed rats exhibited significant increases in body weight, epididymal fat, fasting glucose levels and glucose intolerance compared with SCD group. Platelet aggregation induced by ADP (n = 8) and thrombin from HFD rats (n = 8) were significantly greater (P < 0.05) compared with SCD group. Platelet activation with ADP increased by 54% the intraplatelet ROS production in HFD group, as measured by flow cytometry (n = 6). N-acetylcysteine (NAC; 1 mM) and PEG-catalase (1000 U/ml) fully prevented the increased ROS production and platelet hyperaggregability in HFD group. The NO donors sodium nitroprusside (SNP; 10 mu M) and SNAP (10 mu M), as well as the NO-independent soluble guanylyl cyclase stimulator BAY 41-2272 (10 mu M) inhibited the platelet aggregation in HFD group with lower efficacy (P < 0.05) compared with SCD group. The cGMP levels in response to these agents were also markedly lower in HFD group (P < 0.05). The prostacyclin analogue iloprost (1 mu M) reduced platelet aggregation in HFD and SCD rats in a similar fashion (n = 4). Conclusions: Metabolic abnormalities as consequence of HFD cause platelet hyperaggregability involving enhanced intraplatelet ROS production and decreased NO bioavailability that appear to be accompanied by potential defects in the prosthetic haem group of soluble guanylyl cyclase
Subject: Agregação plaquetária
Obesidade
Óxido nítrico
GMP cíclico
Country: Reino Unido
Editor: Biomed Central
Citation: Cardiovascular Diabetology. Biomed Central Ltd, v.11, 2012
Rights: aberto
Identifier DOI: 10.1186/1475-2840-11-5
Address: https://cardiab.biomedcentral.com/articles/10.1186/1475-2840-11-5
Date Issue: 2012
Appears in Collections:FCM - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
000302474500001.pdf457.87 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.